CSPC INNOVATION PHARMACEUTICAL CO., LTD.

CSPC Innovation Pharmaceutical Co., Ltd.

300765

CNE100003K04

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 04/07/2024 BST			5-day change	1st Jan Change
24.64 ^CNY	+7.18%		-4.86%	-19.26%

07-01	Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	CI
06-21	CSPC Innovation Pharmaceutical Co., Ltd. agreed to acquire CSPC Baike Biopharmaceutical Co., Ltd. from CSPC Weisheng Pharmaceutical (Shijiazhuang) Co. Ltd, CSPC Pharmaceutical Company Ltd and CSPC NBP Pharmaceutical Co., Ltd.	CI

CSPC Innovation Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 million in funding

August 14, 2022

CSPC Innovation Pharmaceutical Co., Ltd. announced a private placement of common shares for gross proceeds of up to CNY 500,000,000 on August 15, 2022.

Latest news about CSPC Innovation Pharmaceutical Co., Ltd.

Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	07-01	CI
CSPC Innovation Pharmaceutical Co., Ltd. agreed to acquire CSPC Baike Biopharmaceutical Co., Ltd. from CSPC Weisheng Pharmaceutical (Shijiazhuang) Co. Ltd, CSPC Pharmaceutical Company Ltd and CSPC NBP Pharmaceutical Co., Ltd.	06-20	CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
China's drugmakers can't sell mRNA shots but haven't quit yet	04-19	RE
CSPC Innovation Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	04-09	CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	04-01	CI
CSPC Innovation Pharmaceutical Co., Ltd.(XSEC:300765) added to FTSE All-World Index	03-17	CI
CSPC Innovation Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	03-15	CI
CSPC Innovation Pharmaceutical's Attributable Profit Rises 4%; Shares Jump 6%	03-15	MT
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
CSPC Baike's 2023 Profit Reaches 859 Million Yuan	01-25	MT
CSPC Innovation Pharmaceutical Co., Ltd. announced a financing transaction	01-22	CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	01-03	CI
CSPC Innovation Pharmaceutical Co., Ltd.(SZSE:300765) added to Shenzhen Stock Exchange Component A Share Index	12-12	CI
CSPC Innovation Pharmaceutical Co., Ltd.(SZSE:300765) added to Shenzhen Stock Exchange Component Index	12-12	CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	11/10/23	CI
CSPC Innovation Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 421.8 million worth of its shares.	21/09/23	CI
CSPC Innovation Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	19/09/23	CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23	CI
China’s NMPA Accepts CSPC Pharma’s License Application for Asthma Drug	27/06/23	MT
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Cspc Innovation Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on April 27, 2023	20/04/23	CI
CSPC Innovation Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022	10/04/23	CI
CSPC Innovation Pharmaceutical Co., Ltd. Approves Board Appointments	10/04/23	CI

Chart CSPC Innovation Pharmaceutical Co., Ltd.

Duration

Period

Chart CSPC Innovation Pharmaceutical Co., Ltd.

More charts

CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.

Sector

Food Processing

Calendar

15/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for CSPC Innovation Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

24.64 CNY

Average target price

40.1 CNY

Spread / Average Target

+62.73%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-19.26%	4.44B
ZHEJIANG NHU COMPANY LTD.	+13.33%	8.17B
BELLRING BRANDS, INC.	+6.62%	7.71B
THE SIMPLY GOOD FOODS COMPANY	-8.54%	3.59B
BYHEALTH CO., LTD	-20.61%	3.14B
XIAMEN KINGDOMWAY GROUP COMPANY	-12.55%	1.2B
HERBALIFE LTD.	-26.47%	1.14B
JAMIESON WELLNESS INC.	-7.63%	888M
USANA HEALTH SCIENCES, INC.	-17.95%	857M
SIRIO PHARMA CO., LTD.	-11.48%	767M

Special Foods & Wellbeing Products